Dedalus Group, leader in Europe and one of the world's leading players in clinical and healthcare information systems supporting clinical professionals and healthcare facilities thanks to a wide portfolio of innovative products, has appointed Andrea Fiumicelli as CEO of the Group. 
With its teamplay myCare Companion software, the company is bringing a new and flexible telemedicine solution to the market that enables remote care for patients with chronic diseases. The teamplay myCare Companion allows healthcare providers to design their own telemedicine programs and flexibly adapt the underlying technology to their needs. 
HealthTunes has announceed the launch of the iOS App specifically created to help alleviate the mental health suffering of frontline healthcare workers. After months of fighting the pandemic, many frontline workers are suffering from burnout and post-traumatic stress disorder (PTSD). In the general population, after months of lockdown, job loss, and uncertainty, stress and anxiety has skyrocketed as well. 
SilverCloud, the leading digital therapeutics provider, has partnered with mental health charity Northpoint Wellbeing to co-develop a new digital therapy programme to alleviate anxiety in young people. Coming at a time when children are returning to school and face huge uncertainty, it will be available for school clusters across the Leeds area and NHS Child and Adolescent Services Mental Health Services (CAMHS) in Calderdale. 
North Staffordshire Combined Healthcare NHS Trust has selected the DXC Open Health Connect platform from DXC Technology (NYSE: DXC) and is creating a blueprint that could dramatically reduce mental health referral times in order to provide the right assistance for at-risk children through the use of digital technology. 
Highland Marketing has welcomed a new member to its advisory board of respected NHS IT leaders and health tech industry professionals.
Nicola Haywood-Alexander, a chief information officer and digital transformation adviser, who has worked in both the NHS and the wider public sector, has joined the expert group that provides advice to the health tech agency and its clients.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its wearable biosensor (Philips Biosensor BX100) to help manage confirmed and suspected COVID-19 patients in the hospital.